Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Completed 54Terminated 8Recruiting 8Unknown 5Withdrawn 4No longer available 2Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Sarcoma 3Gynecologic 2Classical hematology 1

Conditions

Sarcoma 3Ovarian Neoplasms 2Sarcoma, Ewing 1Rhabdomyosarcoma 1Osteosarcoma 1Fanconi Anemia, Complementation Group D1 1Chondrosarcoma 1Bone Neoplasms 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Unknown × Trabectedin × Clear all
NCT03985722 2023-03-27

OLATRASTS

Grupo Espanol de Investigacion en Sarcomas

Phase 1 Unknown
28 enrolled
Sarcoma

Sarcoma

NCT05131386 2023-03-27

SYNERGIAS

Grupo Espanol de Investigacion en Sarcomas

Phase 2 Unknown
85 enrolled
Sarcoma

Bone Neoplasms, Chondrosarcoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT02359474 2023-02-28

HyperTET

Ludwig-Maximilians - University of Munich

Phase 2 Unknown
120 enrolled
Sarcoma

Sarcoma

NCT03446495 2018-02-26

Renaissance

Scientific Medical Society, Kazakhstan

Unknown
60 enrolled
Gynecologic

Ovarian Neoplasms

NCT01772979 2013-01-21

MITO15

Catholic University of the Sacred Heart

Phase 2 Unknown
100 enrolled
Classical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡